Dustin Haines
Gilead Sciences names its new health leader for Asia markets
Gilead Sciences names its new health leader for Asia markets
Dustin Haines has 20 years leadership in pharmaceuticals.
Most Read
1. Asian medical device markets face cost shocks amidst Iran conflict 2. Gene and cell therapy boom drives DNA manufacturing market toward $21.82B by 2034 3. HSA to expand role in accelerating biomedical sector growth: Ong Ye Kung 4. How do rising claims drive healthcare investment strategy? 5. SingHealth opens off-site MRI centre at Dunearn VillageResource Center
Read Here
Advertise
Sign Up
Events
Event News
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.
Commentary
Beyond ChatGPT: The rise of multimodal AI assistants in clinical settings
2026 biotech playbook: Hong Kong at the centre of China’s globalisation